AMINOSYN II 8.5% INJECTION SOLUTION Canada - engelsk - Health Canada

aminosyn ii 8.5% injection solution

hospira healthcare ulc - l-isoleucine; l-leucine; l-lysine (l-lysine acetate); methionine; l-phenylalanine; l-threonine; tryptophan; l-valine; l-alanine; l-arginine; l-aspartic acid; glutamic acid; glycine; histidine; l-proline; serine; n-acetyl-l-tyrosine - solution - 561mg; 850mg; 893mg; 146mg; 253mg; 340mg; 170mg; 425mg; 844mg; 865mg; 595mg; 627mg; 425mg; 255mg; 614mg; 450mg; 230mg - l-isoleucine 561mg; l-leucine 850mg; l-lysine (l-lysine acetate) 893mg; methionine 146mg; l-phenylalanine 253mg; l-threonine 340mg; tryptophan 170mg; l-valine 425mg; l-alanine 844mg; l-arginine 865mg; l-aspartic acid 595mg; glutamic acid 627mg; glycine 425mg; histidine 255mg; l-proline 614mg; serine 450mg; n-acetyl-l-tyrosine 230mg - caloric agents

AMINOSYN II 7% INJECTION SOLUTION Canada - engelsk - Health Canada

aminosyn ii 7% injection solution

hospira healthcare ulc - glutamic acid; glycine; histidine; l-proline; l-lysine (l-lysine acetate); methionine; l-phenylalanine; l-threonine; tryptophan; l-valine; l-alanine; l-arginine; l-aspartic acid; serine; n-acetyl-l-tyrosine; l-isoleucine; l-leucine - solution - 517mg; 350mg; 210mg; 505mg; 735mg; 120mg; 209mg; 280mg; 140mg; 350mg; 695mg; 713mg; 490mg; 371mg; 189mg; 462mg; 700mg - glutamic acid 517mg; glycine 350mg; histidine 210mg; l-proline 505mg; l-lysine (l-lysine acetate) 735mg; methionine 120mg; l-phenylalanine 209mg; l-threonine 280mg; tryptophan 140mg; l-valine 350mg; l-alanine 695mg; l-arginine 713mg; l-aspartic acid 490mg; serine 371mg; n-acetyl-l-tyrosine 189mg; l-isoleucine 462mg; l-leucine 700mg - caloric agents

AMINOSYN II SOLUTION Canada - engelsk - Health Canada

aminosyn ii solution

icu medical canada inc - l-isoleucine; l-leucine; l-lysine (l-lysine acetate); methionine; l-phenylalanine; l-threonine; tryptophan; l-valine; l-alanine; l-arginine; l-aspartic acid; glutamic acid; glycine; histidine; l-proline; serine; n-acetyl-l-tyrosine - solution - 660mg; 1000mg; 1050mg; 172mg; 298mg; 400mg; 200mg; 500mg; 993mg; 1018mg; 700mg; 738mg; 500mg; 300mg; 722mg; 530mg; 270mg - l-isoleucine 660mg; l-leucine 1000mg; l-lysine (l-lysine acetate) 1050mg; methionine 172mg; l-phenylalanine 298mg; l-threonine 400mg; tryptophan 200mg; l-valine 500mg; l-alanine 993mg; l-arginine 1018mg; l-aspartic acid 700mg; glutamic acid 738mg; glycine 500mg; histidine 300mg; l-proline 722mg; serine 530mg; n-acetyl-l-tyrosine 270mg - caloric agents

AMINOSYN II SOLUTION Canada - engelsk - Health Canada

aminosyn ii solution

icu medical canada inc - l-threonine; tryptophan; l-valine; l-lysine (lysine acetate); methionine; l-phenylalanine; l-alanine; l-arginine; l-aspartic acid; glutamic acid; glycine; histidine; l-proline; serine; n-acetyl-l-tyrosine; l-isoleucine; l-leucine - solution - 600mg; 300mg; 750mg; 1575mg; 258mg; 447mg; 1490mg; 1527mg; 1050mg; 1107mg; 750mg; 450mg; 1083mg; 795mg; 405mg; 990mg; 1500mg - l-threonine 600mg; tryptophan 300mg; l-valine 750mg; l-lysine (lysine acetate) 1575mg; methionine 258mg; l-phenylalanine 447mg; l-alanine 1490mg; l-arginine 1527mg; l-aspartic acid 1050mg; glutamic acid 1107mg; glycine 750mg; histidine 450mg; l-proline 1083mg; serine 795mg; n-acetyl-l-tyrosine 405mg; l-isoleucine 990mg; l-leucine 1500mg - caloric agents

LUPRON DEPOT POWDER FOR SUSPENSION, SUSTAINED-RELEASE Canada - engelsk - Health Canada

lupron depot powder for suspension, sustained-release

abbvie corporation - leuprolide acetate - powder for suspension, sustained-release - 11.25mg - leuprolide acetate 11.25mg - gonadotropins

APO-DICLOFENAC SOLUTION Canada - engelsk - Health Canada

apo-diclofenac solution

apotex inc - diclofenac sodium - solution - 1.5% - diclofenac sodium 1.5% - other nonsteroidal antiimflammatory agents

ZHENG GU SHUI- camphor, menthol liniment USA - engelsk - NLM (National Library of Medicine)

zheng gu shui- camphor, menthol liniment

guangxi yulin pharmaceutical group co ltd - camphor (synthetic) (unii: 5tjd82a1et) (camphor (synthetic) - unii:5tjd82a1et), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - camphor (synthetic) 5.6 g in 100 ml - purpose external analgesic external analgesic uses for the temporary relief of minor aches and pains of muscles and joints due to: simple backache arthritis strains bruises sprains stop use and ask a doctor if condition worsens symptoms persist for more than 7 days symptoms clear up and occur again within a few days excessive irritation develops nausea, vomiting, abdominal discomfort, diarrhea, or skin rash occurs when using for pain of arthritis: pain persists for more than 10 days redness is present in conditions affecting children under 12 years of age

PYRAZINAMIDE tablet USA - engelsk - NLM (National Library of Medicine)

pyrazinamide tablet

a-s medication solutions - pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - pyrazinamide 500 mg - pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (the current recommendation of the cdc for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.*4 ) (patients with drug-resistant disease should be treated with regimens individualized to their situation. pyrazinamide frequently will be an important component of such therapy.) (in patients with concomitant hiv infection, the physician should be aware of current recommendation of cdc. it is possible these patients may require a longer course of treatment). it is also indicated after treatment failure with other primary drugs in any form of active tuberculosis. pyrazinamide should only be used in conjunction with other effective antituberculous agents. *see recommendations of center for disease control

PYRAZINAMIDE tablet USA - engelsk - NLM (National Library of Medicine)

pyrazinamide tablet

akorn - pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - pyrazinamide 500 mg - pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (the current recommendation of the cdc for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.*4 ) (patients with drug-resistant disease should be treated with regimens individualized to their situation. pyrazinamide frequently will be an important component of such therapy.) (in patients with concomitant hiv infection, the physician should be aware of current recommendation of cdc. it is possible these patients may require a longer course of treatment). it is also indicated after treatment failure with other primary drugs in any form of active tuberculosis. pyrazinamide should only be used in conjunction with other effective antituberculous agents. *see recommendations of center for disease control

PYRAZINAMIDE tablet USA - engelsk - NLM (National Library of Medicine)

pyrazinamide tablet

remedyrepack inc. - pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - pyrazinamide 500 mg